Establishment of primary breast cancer cell line as new model for drug screening and basic research
Background and purpose: In 2016 the National Cancer Institute (NCI) decided stopping to use NCI-60 cell lines for drug screening, suggesting that tumor cell lines were losing their value as a tool for drug discovery and basic research. The reason for NCI-60 cells 'retirement' was that the preclinica...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Editorial Office of China Oncology
2024-06-01
|
| Serie: | Zhongguo aizheng zazhi |
| Soggetti: | |
| Accesso online: | http://www.china-oncology.com/fileup/1007-3639/PDF/1721112103495-1092368142.pdf |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
